Avtor/Urednik | Amir, Eitan; Šeruga, Boštjan; Freedman, Orit; Tannock, Ian | |
Naslov | Lapatinib plus paclitaxel as first-line therapy for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: inappropriate conclusions from a company-sponsored study? | |
Tip | članek | |
Vir | J Clin Oncol | |
Vol. in št. | Letnik 27, št. 11 | |
Leto izdaje | 2009 | |
Obseg | str. 1919 | |
Jezik | eng | |
Deskriptorji | BREAST NEOPLASMS GENES, ERBB-2 PACLITAXEL QUINAZOLINES |